BVS logo

BVS
Bioventus Inc - Ordinary Shares - Class A

441
Mkt Cap
$823.41M
Volume
297,279.00
52W High
$10.76
52W Low
$5.81
PE Ratio
30.12
BVS Fundamentals
Price
$9.87
Prev Close
$9.67
Open
$9.72
50D MA
$9.18
Beta
1.18
Avg. Volume
488,318.94
EPS (Annual)
$0.3299
P/B
3.60
Rev/Employee
$610,846.24
$817.18
Loading...
Loading...
News
all
press releases
Bioventus Inc. (NASDAQ:BVS) Given Average Rating of "Buy" by Brokerages
Shares of Bioventus Inc. (NASDAQ:BVS - Get Free Report) have been given a consensus recommendation of "Buy" by the five analysts that are currently covering the firm, Marketbeat reports. One equities...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·2d ago
News Placeholder
Strength Seen in Bioventus (BVS): Can Its 6.6% Jump Turn into More Strength?
Bioventus (BVS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks·15d ago
News Placeholder
Bioventus (NASDAQ:BVS) Hits New 1-Year High - What's Next?
Bioventus (NASDAQ:BVS) Hits New 52-Week High - Still a Buy...
MarketBeat·17d ago
News Placeholder
Are Investors Undervaluing Bioventus (BVS) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·18d ago
News Placeholder
JPMorgan Chase & Co. Cuts Stock Position in Bioventus Inc. $BVS
JPMorgan Chase & Co. lowered its position in Bioventus Inc. (NASDAQ:BVS - Free Report) by 52.9% during the third quarter, according to the company in its most recent filing with the Securities...
MarketBeat·19d ago
News Placeholder
Bioventus Inc. (NASDAQ:BVS) Given Consensus Rating of "Buy" by Brokerages
Shares of Bioventus Inc. (NASDAQ:BVS - Get Free Report) have received an average rating of "Buy" from the five ratings firms that are covering the stock, Marketbeat Ratings reports. One equities...
MarketBeat·25d ago
News Placeholder
CJS Securities Initiates Coverage on Bioventus (NASDAQ:BVS)
CJS Securities started coverage on Bioventus in a research note on Friday. They issued an "outperform" rating and a $14.00 target price on the stock...
MarketBeat·1mo ago
News Placeholder
Divisadero Street Capital Management LP Sells 385,116 Shares of Bioventus Inc. $BVS
Divisadero Street Capital Management LP lessened its position in Bioventus Inc. (NASDAQ:BVS - Free Report) by 35.6% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·2mo ago
News Placeholder
Michelle Mcmurry-Heath Sells 12,000 Shares of Bioventus (NASDAQ:BVS) Stock
Bioventus Inc. (NASDAQ:BVS - Get Free Report) Director Michelle Mcmurry-Heath sold 12,000 shares of the company's stock in a transaction on Wednesday, March 11th. The stock was sold at an average...
MarketBeat·2mo ago
<
1
2
...
>

Latest BVS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.